Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Minnesota
This is a randomized prospective study with two arms, Drug-Eluting Beads with doxorubicin (DEB) and lipiodol ethanol mixture (LEM), with the goal to show non-inferiority of LEM, which if true will facilitate a simple alternative to DEBs. Patients will be randomized to one arm of the study and will remain in that arm if they need to have more embolization in the future. Both of the mentioned methods (DEB and LEM) fall within the standard of care.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Child-Pugh class A or B
Biopsy proven HCC or hypervascular mass per European Association for the Study of the Liver (EASL) criteria
Patient not a candidate for surgical resection or percutaneous ablation
age \> 18 years old and able to consent
You may not be if
Child-Pugh class C
Model for End-Stage Liver Disease (MELD) score \>16
Extrahepatic disease
Bilateral or main portal vein thrombus
Total bilirubin \> 2.2
Serum albumin \< 2.6
Life expectancy \< 2 months
Uncorrected INR \> 2
Eastern Cooperative Oncology Group (ECOG) status \> 2